prolapse of lumbar intervertebral disc
Conditions
Interventions
Control group (N group):Group N received no special treatment
Research Group (Group D):Group D was given DEX nasal drops one night before the operation, on the day of the operation and on the first night after the operation. Spray 1 spray into each nostril, hold
Sponsors
The Second Hospital of Hebei Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1.The patient meets the diagnostic criteria of Western medicine and has been confirmed by CT or MRI. 2. Conservative treatment has been ineffective for more than three months; 3. Patients and their families are aware of the purpose and process of this study, cooperate in completing the scale scoring and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with skeletal spinal stenosis shown by imaging results; 2. Patients who cannot receive nasal administration, such as those who have undergone nasal surgery or suffered trauma; 3. Those who are allergic to this product and its ingredients; 4. Circulatory system disorders: such as hypotension, bradycardia, sinus arrest, etc. 5. Combined with diseases of the immune system, endocrine system or dysfunction of important organs such as the heart, brain, lungs, liver and kidneys; 6. Allergy to relevant anesthetic drugs; 7. Patients who were unable to complete the scale scoring and refused to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index (PSQI) score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative pain score (VAS);Adverse event records (such as nasal irritation, allergies, daytime sleepiness, etc.);The incidence and severity of nausea and vomiting; | — |
Countries
China
Contacts
Public ContactJunpeng Liu
The Second Hospital Of Hebe Medical University
Outcome results
None listed